Overview Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections Status: Completed Trial end date: 2009-06-01 Target enrollment: Participant gender: Summary Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections Phase: Phase 2 Details Lead Sponsor: TaiGen Biotechnology Co., Ltd.